1. Home
  2. FSFG vs GNFT Comparison

FSFG vs GNFT Comparison

Compare FSFG & GNFT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • FSFG
  • GNFT
  • Stock Information
  • Founded
  • FSFG 2008
  • GNFT 1999
  • Country
  • FSFG United States
  • GNFT France
  • Employees
  • FSFG N/A
  • GNFT N/A
  • Industry
  • FSFG Savings Institutions
  • GNFT Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • FSFG Finance
  • GNFT Health Care
  • Exchange
  • FSFG Nasdaq
  • GNFT Nasdaq
  • Market Cap
  • FSFG N/A
  • GNFT 172.2M
  • IPO Year
  • FSFG 2008
  • GNFT 2019
  • Fundamental
  • Price
  • FSFG $24.99
  • GNFT $3.46
  • Analyst Decision
  • FSFG Buy
  • GNFT Strong Buy
  • Analyst Count
  • FSFG 1
  • GNFT 1
  • Target Price
  • FSFG $31.00
  • GNFT $13.00
  • AVG Volume (30 Days)
  • FSFG 13.6K
  • GNFT 6.4K
  • Earning Date
  • FSFG 01-28-2025
  • GNFT 09-19-2024
  • Dividend Yield
  • FSFG 2.40%
  • GNFT N/A
  • EPS Growth
  • FSFG 66.39
  • GNFT N/A
  • EPS
  • FSFG 1.98
  • GNFT 0.47
  • Revenue
  • FSFG $68,091,000.00
  • GNFT $86,225,222.00
  • Revenue This Year
  • FSFG N/A
  • GNFT $145.20
  • Revenue Next Year
  • FSFG $2.77
  • GNFT N/A
  • P/E Ratio
  • FSFG $12.62
  • GNFT $7.17
  • Revenue Growth
  • FSFG N/A
  • GNFT 175.45
  • 52 Week Low
  • FSFG $14.55
  • GNFT $3.31
  • 52 Week High
  • FSFG $30.94
  • GNFT $6.42
  • Technical
  • Relative Strength Index (RSI)
  • FSFG 38.69
  • GNFT 30.39
  • Support Level
  • FSFG $24.20
  • GNFT $3.44
  • Resistance Level
  • FSFG $27.17
  • GNFT $3.90
  • Average True Range (ATR)
  • FSFG 0.82
  • GNFT 0.14
  • MACD
  • FSFG -0.12
  • GNFT 0.01
  • Stochastic Oscillator
  • FSFG 26.60
  • GNFT 18.64

About GNFT GENFIT S.A.

Genfit SA is a biotechnology company focused on metabolic and inflammatory diseases, with a particular focus on the liver and gastroenterology. The company's research and development activity relies on its expertise in modulating gene expression through nuclear receptors. Genfit utilizes acquisitions, strategic alliances, and licensing agreements in order to fund the further development of its products. It has one segment the research and development of innovative medicines and diagnostic solutions, the marketing of which depends on the success of the clinical development phase.

Share on Social Networks: